Quarterly Result21 May 2026, 05:41 pm
Genpharmasec Approves Audited FY26 Financial Results
AI Summary
Genpharmasec Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board also approved the re-appointment of M/s. Abhishek M Agrawal & Co. as Internal Auditor for the financial year 2026-2027. The meeting, held on May 21, 2026, commenced at 4:30 p.m. and concluded at 05:15 p.m.
Key Highlights
- Audited standalone and consolidated financial results for FY26 approved.
- M/s. Abhishek M Agrawal & Co. re-appointed as Internal Auditor for FY27.
- Statutory Auditors issued an Audit Report with Unmodified Opinion.
- Board meeting held on May 21, 2026, to approve the results.
Price Impact
More from GENPHARMA
More in Quarterly Result